Interestingly, in 2017, Borellini et al. reported a Filipino woman with homozygous L347P PINK1 mutation with severe lower limb dystonia, gait abnormalities and dyskinesias who was treated with STN-DBS. The gene discussed is PINK1; the disease is drug-induced dyskinesia.